Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Helios Klinikum Bad Saarow

Pieskower Straße 33     
Bad Saarow , 15526
Germany

 

Principal Investigator:
 Peter Reichardt, MD
Contact:
 Simone Micheel +49 (0) 336 317 3728 simone.micheel@helios-kliniken.de
Activation Status of this Site:
 Closed
Notes about this Site:
Helios Klinikum Bad Saarow Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.